|
Volumn 36, Issue 2, 2004, Pages 379-380
|
Infectious enteritis after intestinal transplantation: Incidence, timing, and outcome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
DACLIZUMAB;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
ADENOVIRUS;
BIOPSY;
CHILD;
CLINICAL ARTICLE;
CLOSTRIDIUM DIFFICILE;
CONFERENCE PAPER;
CONSERVATIVE TREATMENT;
CONTROLLED STUDY;
CRYPTOSPORIDIUM;
CYTOMEGALOVIRUS;
DEMOGRAPHY;
ENTERITIS;
EPIDEMIOLOGICAL DATA;
EPSTEIN BARR VIRUS;
FEMALE;
GIARDIA LAMBLIA;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
INTESTINE TRANSPLANTATION;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
ROTAVIRUS;
VIRUS VIRULENCE;
ADULT;
BACTERIAL INFECTIONS;
CHILD;
ENTERITIS;
FEMALE;
HUMANS;
INTESTINES;
MALE;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TREATMENT OUTCOME;
VIRUS DISEASES;
|
EID: 12144286068
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.01.093 Document Type: Conference Paper |
Times cited : (26)
|
References (5)
|